Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination

Journal of Immunology

Volumn 191, Issue 2, 2013, Pages 623-631

  Bonduelle, Olivia ^a   Yahia, Nora ^a   Siberil, Sophie ^a   Benhabiles, Nora ^b   Carrat, Fabrice ^a   Krivine, Anne ^c   Rozenberg, Flore ^c   Dimitrov, Jordan ^d   Kaveri, Srini V ^d   Curjol, Angélique ^e   Tindel, Malka ^e   Louet, Martine ^e   Desert, Florent ^e   Launay, Odile ^a   Loulergue, Pierre ^a   Badre, Gwenaelle ^a   Katlama, Christine ^e   Bricaire, François ^e   Samri, Assia ^a   Rousset, Dominique ^f   Van Werf, Sylvie Der ^f   Jauréguiberry, Stephane ^e   Combadiere, Behazine ^a,e   more..

^a INSERM   (France)

^b CEA SACLAY   (France)

^c Institut Cochin   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE;

ADULT; ARTICLE; BIOLOGICAL MODEL; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DRUG EFFICACY; DRUG QUALITY; EFFECTOR CELL; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOASSAY; IMMUNOGENICITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MEMORY CELL; PANDEMIC INFLUENZA; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; SEASONAL INFLUENZA; SECRETORY CELL; SINGLE DRUG DOSE; UPREGULATION; VIRUS HEMAGGLUTINATION;

ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PRINCIPAL COMPONENT ANALYSIS; VACCINATION; VACCINES, INACTIVATED;

EID: 84880126193     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203483     Document Type: Article

References (47)

1. Hobson, D., R. L. Curry, A. S. Beare, and A. Ward-Gardner. 1972. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. (Lond.) 70: 767-777.
2. Sasaki, S., M. C. Jaimes, T. H. Holmes, C. L. Dekker, K. Mahmood, G. W. Kemble, A. M. Arvin, and H. B. Greenberg. 2007. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J. Virol. 81: 215-228. (Pubitemid 44975162)
3. Wrammert, J., K. Smith, J. Miller, W. A. Langley, K. Kokko, C. Larsen, N. Y. Zheng, I. Mays, L. Garman, C. Helms, et al. 2008. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453: 667-671. (Pubitemid 351769295)
4. Arulanandam, B. P., R. H. Raeder, J. G. Nedrud, D. J. Bucher, J. Le, and D.W. Metzger. 2001. IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection. J. Immunol. 166: 226-231. (Pubitemid 32038436)
5. Monsalvo, A. C., J. P. Batalle, M. F. Lopez, J. C. Krause, J. Klemenc, J. Z. Hernandez, B. Maskin, J. Bugna, C. Rubinstein, L. Aguilar, et al. 2011. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 17: 195-199.
6. Renegar, K. B., P. A. Small, Jr., L. G. Boykins, and P. F. Wright. 2004. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J. Immunol. 173: 1978-1986. (Pubitemid 38971634)
7. Khurana, S., N. Verma, K. R. Talaat, R. A. Karron, and H. Golding. 2012. Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender. J. Infect. Dis. 205: 610-620.
8. Larson, H. E., D. A. Tyrrell, C. H. Bowker, C. W. Potter, and G. C. Schild. 1978. Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2). J. Hyg. (Lond.) 80: 243-248. (Pubitemid 8310425)
9. McMichael, A. J., F. M. Gotch, D. W. Dongworth, A. Clark, and C. W. Potter. 1983. Declining T-cell immunity to influenza, 1977-82. Lancet 2: 762-764. (Pubitemid 13003945)
10. Seder, R. A., P. A. Darrah, and M. Roederer. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8: 247-258. (Pubitemid 351432801)
11. Wagar, L. E., L. Rosella, N. Crowcroft, B. Lowcock, P. C. Drohomyrecky, J. Foisy, J. Gubbay, A. Rebbapragada, A. L. Winter, C. Achonu, et al. 2011. Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination. PLoS ONE 6: e28063.
12. McMichael, A. J., and B. A. Askonas. 1978. Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell. Eur. J. Immunol. 8: 705-711. (Pubitemid 9031550)
13. McMichael, A. J., F. M. Gotch, G. R. Noble, and P. A. Beare. 1983. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309: 13-17. (Pubitemid 13062888)
14. Plotkin, S. A. 2008. Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 47: 401-409.
15. Belz, G. T., D. Wodarz, G. Diaz, M. A. Nowak, and P. C. Doherty. 2002. Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J. Virol. 76: 12388-12393. (Pubitemid 35304341)
16. Eichelberger, M., W. Allan, M. Zijlstra, R. Jaenisch, and P. C. Doherty. 1991. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J. Exp. Med. 174: 875-880.
17. Biddison, W. E., S. Shaw, and D. L. Nelson. 1979. Virus specificity of human influenza virus-immune cytotoxic T cells. J. Immunol. 122: 660-664. (Pubitemid 9116095)
18. Greenbaum, J. A., M. F. Kotturi, Y. Kim, C. Oseroff, K. Vaughan, N. Salimi, R. Vita, J. Ponomarenko, R. H. Scheuermann, A. Sette, and B. Peters. 2009. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc. Natl. Acad. Sci. USA 106: 20365-20370.
19. Kendal, A. P., and T. R. Cate. 1983. Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79. J. Clin. Microbiol. 18: 930-934. (Pubitemid 13005425)
20. Dimitrov, J. D., S. Lacroix-Desmazes, and S. V. Kaveri. 2011. Important parameters for evaluation of antibody avidity by immunosorbent assay. Anal. Biochem. 418: 149-151.
21. Crotty, S., R. D. Aubert, J. Glidewell, and R. Ahmed. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286: 111-122. (Pubitemid 38490401)
22. Saeed, A. I., V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati, J. Braisted, M. Klapa, T. Currier, M. Thiagarajan, et al. 2003. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378. (Pubitemid 36184095)
23. Yeung, K. Y., D. R. Haynor, and W. L. Ruzzo. 2001. Validating clustering for gene expression data. Bioinformatics 17: 309-318. (Pubitemid 32421924)
24. Soukas, A., P. Cohen, N. D. Socci, and J. M. Friedman. 2000. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev. 14: 963-980. (Pubitemid 30253005)
25. Greenberg, M. E., M. H. Lai, G. F. Hartel, C. H. Wichems, C. Gittleson, J. Bennet, G. Dawson,W. Hu, C. Leggio, D. Washington, and R. L. Basser. 2009. Response to a monovalent 2009 influenza A (H1N1) vaccine. N. Engl. J. Med. 361: 2405-2413.
26. Hancock, K., V. Veguilla, X. Lu, W. Zhong, E. N. Butler, H. Sun, F. Liu, L. Dong, J. R. DeVos, P. M. Gargiullo, et al. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361: 1945-1952.
27. Madhun, A. S., P. E. Akselsen, H. Sjursen, G. Pedersen, S. Svindland, J. K. Nøstbakken, M. Nilsen, K. Mohn, A. Jul-Larsen, I. Smith, et al. 2010. An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine 29: 266-273.
28. Roman, F., T. Vaman, B. Gerlach, A. Markendorf, P. Gillard, and J. M. Devaster. 2010. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial. Vaccine 28: 1740-1745.
29. Daffertshofer, A., C. J. Lamoth, O. G. Meijer, and P. J. Beek. 2004. PCA in studying coordination and variability: a tutorial. Clin. Biomech. (Bristol, Avon) 19: 415-428. (Pubitemid 38510420)
30. Roden, J. C., B. W. King, D. Trout, A. Mortazavi, B. J. Wold, and C. E. Hart. 2006. Mining gene expression data by interpreting principal components. BMC Bioinformatics 7: 194.
31. Roman, F., F. Clément, W. Dewé, K. Walravens, C. Maes, J. Willekens, F. De Boever, E. Hanon, and G. Leroux-Roels. 2011. Effect on cellular and humoral immune responses of the AS03 adjuvant system in an A/H1N1/2009 influenza virus vaccine administered to adults during two randomized controlled trials. Clin. Vaccine Immunol. 18: 835-843.
32. Combadiere, B., and C. Liard. 2011. Transcutaneous and intradermal vaccination. Hum. Vaccin. 7: 811-827.
33. Durando, P., R. Iudici, C. Alicino, M. Alberti, D. de Florentis, F. Ansaldi, and G. Icardi. 2011. Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine. Hum. Vaccin. 7(Suppl.): 29-40.
34. Brown, D. M., A. M. Dilzer, D. L. Meents, and S. L. Swain. 2006. CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J. Immunol. 177: 2888-2898. (Pubitemid 44277804)
35. Doherty, P. C., S. J. Turner, R. G. Webby, and P. G. Thomas. 2006. Influenza and the challenge for immunology. Nat. Immunol. 7: 449-455.
36. Strutt, T. M., K. K. McKinstry, J. P. Dibble, C. Winchell, Y. Kuang, J. D. Curtis, G. Huston, R. W. Dutton, and S. L. Swain. 2010. Memory CD4+ T cells induce innate responses independently of pathogen. Nat. Med. 16: 558-564, 1p following 564.
37. Galli, G., D. Medini, E. Borgogni, L. Zedda, M. Bardelli, C. Malzone, S. Nuti, S. Tavarini, C. Sammicheli, A. K. Hilbert, et al. 2009. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc. Natl. Acad. Sci. USA 106: 3877-3882.
38. Pelat, C., A. Falchi, F. Carrat, A. Mosnier, I. Bonmarin, C. Turbelin, S. Vaux, S. van der Werf, J. M. Cohen, B. Lina, et al. 2011. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS ONE 6: e19621.
39. Monto, A. S., and A. P. Kendal. 1973. Effect of neuraminidase antibody on Hong Kong influenza. Lancet 1: 623-625.
40. Wilkinson, T. M., C. K. Li, C. S. Chui, A. K. Huang, M. Perkins, J. C. Liebner, R. Lambkin-Williams, A. Gilbert, J. Oxford, B. Nicholas, et al. 2012. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18: 274-280.
41. Maecker, H. T., J. P. McCoy, and R. Nussenblatt. 2012. Standardizing immunophenotyping for the Human Immunology Project. Nat. Rev. Immunol. 12: 191-200.
42. Monaco, A., F. M. Marincola, M. Sabatino, Z. Pos, M. L. Tornesello, D. F. Stroncek, E. Wang, G. K. Lewis, F. M. Buonaguro, and L. Buonaguro. 2009. Molecular immune signatures of HIV-1 vaccines in human PBMCs. FEBS Lett. 583: 3004-3008.
43. Nakaya, H. I., J. Wrammert, E. K. Lee, L. Racioppi, S. Marie-Kunze, W. N. Haining, A. R. Means, S. P. Kasturi, N. Khan, G. M. Li, et al. 2011. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12: 786-795.
44. Querec, T. D., R. S. Akondy, E. K. Lee, W. Cao, H. I. Nakaya, D. Teuwen, A. Pirani, K. Gernert, J. Deng, B. Marzolf, et al. 2009. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10: 116-125.
45. Aricò, E., E. Wang, M. L. Tornesello, M. Tagliamonte, G. K. Lewis, F. M. Marincola, F. M. Buonaguro, and L. Buonaguro. 2005. Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation. J. Transl. Med. 3: 45.
46. Buonaguro, L., A. Monaco, E. Aricò, E. Wang, M. L. Tornesello, G. K. Lewis, F. M. Marincola, and F. M. Buonaguro. 2008. Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation. BMC Bioinformatics 9(Suppl. 2): S5.
47. Gaucher, D., R. Therrien, N. Kettaf, B. R. Angermann, G. Boucher, A. Filali-Mouhim, J. M. Moser, R. S. Mehta, D. R. Drake, III, E. Castro, et al. 2008. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205: 3119-3131.